摘要
目的探析晚期肝癌应用计算机断层扫描(CT)引导下经皮靶向综合疗法的临床效果。方法 2010年8月至2014年4月间102例晚期肝癌患者,按随机数字表法分为观察组和对照组,每组61例。治疗组应用CT引导下经皮靶向综合疗法,对照组实施动脉栓塞化疗法,比较两组患者治疗后的临床效果和生存率情况。结果观察组和对照组患者的临床有效率分别为76.5%和52.9%,差异有统计学意义(P<0.05)。观察组患者的1、3、5年生存率明显高于对照组,差异有统计学意义(P<0.05)。结论肝癌晚期患者进行CT引导下经皮靶向综合疗法,临床效果确切,治疗后生存率得到提高,并可延缓病情进展,值得临床推广。
Objective To study the clinical application value of computed tomography （CT）- guided percutaneous comprehensive targeting treatment in the advanced hepatocellular carcinoma （I-iCC）. Methods 102 cases with advanced HCC in The Second People＇s Hospital of Panzhihua City from August 2010 to April 2014 were randomly divided into observation group and control group, each group of 61 cases. The treatment group used CT-guided percutaneous targeted treatment, and the control group received arterial embolization. Rate of survival and clinical effect of treatment were compared between two group. Results The clinical effective rate of observation group and the control group were 76. 5%, 52. 9% respectively, and the difference was statistically significant （P 〈 0. 05 ）. The l-yr, 3-yr, 5-yr survival rates of the observation group were significantly higher than those in the control group, （P 〈 0. 05 ）. Conclusions As for its good clinical effect, high survival rate and solwing the progression of the disease, CT-guided percutaneous com- prehensive targeting treatment in the advanced HCC is worthy of clinical use.
出处
《中国肿瘤临床与康复》
2015年第5期568-570,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
临床效果
肝癌晚期
CT引导经皮靶向
Clinical application
Hepatocellular carcinoma
CT-guided percu^aneous compre-hensive targeting treatment
